BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35548971)

  • 1. Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment.
    Zhang D; Zhao Y; Wang L; You X; Li J; Zhang G; Hou Y; Wang H; He S; Li E
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):227-240. PubMed ID: 35548971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection.
    Zhang D; Zhao Y; You X; He S; Li E
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0148722. PubMed ID: 36853000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Fiber Degeneration Enhances Alveolar Macrophage-Mediated IFN-α/β Response to Respiratory Syncytial Virus.
    He Y; Li C; Wang Z; Yang Z; Wei J; Ren L; Deng Y; Chen S; Ye Z; Zang N; Liu E
    Microbiol Spectr; 2022 Dec; 10(6):e0241022. PubMed ID: 36350149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    Huang S; Zhu B; Cheon IS; Goplen NP; Jiang L; Zhang R; Peebles RS; Mack M; Kaplan MH; Limper AH; Sun J
    J Virol; 2019 May; 93(9):. PubMed ID: 30787149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus impairs macrophage IFN-alpha/beta- and IFN-gamma-stimulated transcription by distinct mechanisms.
    Senft AP; Taylor RH; Lei W; Campbell SA; Tipper JL; Martinez MJ; Witt TL; Clay CC; Harrod KS
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):404-14. PubMed ID: 19502390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine (C-X-C Motif) Ligand 4 Is a Restrictor of Respiratory Syncytial Virus Infection and an Indicator of Clinical Severity.
    Han Z; Rao J; Xie Z; Wang C; Xu B; Qian S; Wang Y; Zhu J; Yang B; Xu F; Lei X; Guo F; Zhao Z; Ren L; Wang J
    Am J Respir Crit Care Med; 2020 Sep; 202(5):717-729. PubMed ID: 32543879
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
    Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
    J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.
    Shibata T; Makino A; Ogata R; Nakamura S; Ito T; Nagata K; Terauchi Y; Oishi T; Fujieda M; Takahashi Y; Ato M
    J Clin Invest; 2020 Jun; 130(6):3021-3037. PubMed ID: 32364537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Role of the NF-κB Pathway in the
    Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins.
    Zhang W; Zhang L; Zan Y; Du N; Yang Y; Tien P
    J Gen Virol; 2015 Jan; 96(Pt 1):170-182. PubMed ID: 25228491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
    Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
    J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis.
    Ji JJ; Sun QM; Nie DY; Wang Q; Zhang H; Qin FF; Wang QS; Lu SF; Pang GM; Lu ZG
    Acta Pharmacol Sin; 2021 Oct; 42(10):1630-1641. PubMed ID: 33495515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of IFN-I responses by the aminopeptidase IRAP in neonatal C57BL/6 alveolar macrophages during RSV infection.
    Drajac C; Laubreton D; Marquant Q; Chottin C; Ferret C; Bouguyon E; Schwartz-Cornil I; Saveanu L; Riffault S; Descamps D
    Mucosal Immunol; 2021 Jul; 14(4):949-962. PubMed ID: 33846534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.
    Shibata T; Habiel DM; Coelho AL; Kunkel SL; Lukacs NW; Hogaboam CM
    J Immunol; 2014 Apr; 192(8):3569-81. PubMed ID: 24659691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages.
    Pokharel SM; Shil NK; Bose S
    Front Cell Infect Microbiol; 2016; 6():174. PubMed ID: 28018859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF treatment prevents respiratory syncytial virus-induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation.
    Naessens T; Schepens B; Smet M; Pollard C; Van Hoecke L; De Beuckelaer A; Willart M; Lambrecht B; De Koker S; Saelens X; Grooten J
    J Allergy Clin Immunol; 2016 Mar; 137(3):700-9.e9. PubMed ID: 26560044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner.
    Qi F; Wang D; Liu J; Zeng S; Xu L; Hu H; Liu B
    Int Immunopharmacol; 2015 Dec; 29(2):408-415. PubMed ID: 26603638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease.
    Cho HY; Imani F; Miller-DeGraff L; Walters D; Melendi GA; Yamamoto M; Polack FP; Kleeberger SR
    Am J Respir Crit Care Med; 2009 Jan; 179(2):138-50. PubMed ID: 18931336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.